Chantix Lawsuits

The anti smoking drug have chantix have increased risks of suicide depression and unusual behavior. Certain patients also complained that they could not stop crying for 5 days while they were on chantix. Other studies have also shown that this smoking cessation drug have caused patients to become hostile, aggression, homicidal thoughts and actions. The FDA has reported that these behavioral changes can arise due to the Nicotine withdrawal symptoms or due to the alterations occurring in the brain.

There are certain psychiatric problems that are the problems which affect our mental health adversely. Such as abnormal dreams, nightmares, aggression, restlessness, agitation, abnormal thinking, erotic behavior, bradyphrenia, euphoric mood. Chantix affects our nervous system causing headache, fatigue, amnesia, migraine, dizziness, sensory disturbance and some visual side effects have been reported. Endocrine problems have also been seen such as Thyroid gland disorder and diabetes mellitus. Chantix can also cause eye irritation, dry eye, conjunctivitis, blurred vision, visual disturbance, night blindness, and pain in the eyes. You can also notice problems with the skin such as skin getting dry on some problems of infrequent acne. Before taking Chantix, tell your doctor about any problems with mental health or high depression in your past.

Chantix should not be taken with other Quit smoking medicines and should only be taken when your doctor prescribes it for you. The dosage of Chantix should also be taken care on.

Potential lawsuits are being by attorneys on behalf of individuals throughout the United States. All federal Chantix lawsuits have been consolidated in an MDL that is centralized in the U.S. District Court for the Northern District of Alabama. When Chantix was introduced, Pfizer failed to adequately research their medication or provide adequate warnings to users and the medical community about the potential side effects, which could increase the risk of suicide or unusual behavior changes. Following hundreds of reported problems, information was added to the warning label about the psychiatric side effects and users are now provided with a medication guide outlining the risks that could be associated with the use of Chantix.

Three new Chantix lawsuits were filed last week in New York state court against Pfizer, Inc., the manufacturer of the popular smoking cessation drug. The cases were filed on behalf of individuals who claim that side effects of Chantix caused users to commit or attempt suicide, adding to the mounting number of similar suits filed against the drug maker in both state and federal courts. The two recent New York state court Chantix lawsuit complaints were filed last week in the Supreme Court in Manhattan. They were brought on behalf of two plaintiffs who allegedly attempted suicide and one woman who killed herself while using the drug. According to the complaints, Pfizer intentionally, recklessly, and negligently concealed or misrepresented the Chantix health risks.

Last year, the FDA required that a new Chantix black box warning be placed prominently on the label to warn users about the potentially life-threatening side effects, which is the strongest warning that can be placed on a prescription medication.

Studies show that Chantix may lead to psychological problems and suicidal tendencies. If you or someone you love has suffered psychological side effects while taking this popular anti-smoking medication, you are not alone.

In fact, the Food and Drug Administration (FDA) has received reports of 98 suicides and over 180 attempted suicides in people taking Chantix. Many other users report symptoms such as depression, nightmares, and violent tendencies. The FDA now requires Chantix to carry a black box warning - the most serious warning the agency can issue.

If you or someone you love has suffered adverse health effects because of Chantix, you may be entitled to take legal action against its manufacturer, Pfizer. With a strong case, you may be able to recover damages for medical bills, property damage, pain and suffering, and other losses caused by Chantix.

On February 1st, 2008, the Food and Drug Administration (FDA) issued a public health advisory, giving new information about the risks of taking the prescription medicine Chantix, or Varencline Tart rate. Further, it reiterated the necessity of communication between patients and their doctors regarding previous psychiatric illness, stating again that Varencline could not only be responsible for new conditions, but also exacerbate existing conditions or rekindle previous conditions. Patients taking Chantix should immediately report changes in mood and behavior to their doctor.

The company Pfizer was hit hard by the settlement of a suicide case with the amount of 2.3 billion dollars. The FDA has reported 491 cases of suicidal thinking or behavior, including 420 in the US. And of those, there were 39 suicides, including 34 in the US.

Chantix (varenicline) was approved in 2006 to help people quit smoking. It works by stimulating nicotine receptors in the brain, just as nicotine does, but blocks the nicotine from attaching to the receptors, reducing the pleasurable effects of tobacco as well as the desire to smoke. Because it works on the brain, Chantix may worsen preexisting psychiatric illness or cause a recurrence of past issues. However, some Chantix users who had no history of psychiatric illness and others who did not quit smoking also reported behavior or mood changes, including suicidal thoughts.

There are also reports of patients experiencing drowsiness that affected their ability to drive or operate machinery. The Federal Motor Carrier Safety Administration announced that the use of Chantix may adversely affect a driver's ability to safely operate a commercial motor vehicle and the FAA banned the use of Chantix among pilots and air traffic controllers.

A preliminary assessment revealed that many of the cases reflect new-onset of depressed mood, suicidal ideation, and changes in emotion and behavior within days to weeks of initiating Chantix treatment.

Lawsuits have been filed against Pfizer Inc., the maker of Chantix, alleging Chantix side effects caused users to commit or attempt suicide and that Pfizer failed to properly warn users and the medical community about the potential side effects, which could increase the risk of suicide or unusual behavior changes. The lawsuits also claim that Pfizer failed to adequately research their medication.